Division of Stem Cells & Cancer Therapeutics

The Division of Stem Cell Biology Research, previously Directed by Yanhong Shi (2015-2022), has been renamed Division of Stem Cells and Cancer Therapeutics and is currently under the leadership of Dr. Karen Aboody.

The Division of Stem Cells and Cancer Therapeutics, reflects the efforts and the commitment of the Department of Stem Cell Biology and Regenerative Medicine to Translational Medicine. Dr. Aboody has a longstanding track record in translating basic research into the clinics. The division includes faculty with clinical research expertise and provides guidance to all researchers in the Dept. in developing IND and move forward to clinical trials.